(Published in Part II, Section 3, Sub-section (ii) of
the Gazette of India, Extraordinary, dated the 27th November, 2008)
Government of India
Ministry of Chemicals and Fertilizers
National Pharmaceutical Pricing Authority
New Delhi, the 27th November, 2008
ORDER
S.O. 2803(E)- In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Pfizer Products India Pvt. Ltd.
TABLE
Sl. No. | Name of the formulation | Pack Size | Existing Retail Price Excise (Rs.) | Retail Price without Excise Duty Sales Tax /VAT and Local Tax, if any (Rs.) | Equivalent MRP* inclusive of all taxes (Rs.) |
---|---|---|---|---|---|
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Solu Medrol AOV 500 mg Each ml containsethyl Prednisolone Sodium Succinate – 500 mg Batch No. OATJ4 / Qty. 23576 Vials imported | 4ml Vial | 568.82 | 596.09 | 619.93 |
2 | Solu Medrol AOV 1000 mg Each ml containsMethyl Prednisolone Sodium Succinate – 1000 mgBatch No. OATXC / Qty. 29637 Vials imported Batch No. OAWHS / Qty. 33640 Vials imported | 8ml Vial | 911.76 | 967.11 | 1005.79 |
3 | Depo – Medrol 80 mg Each ml containsMethyl Prednisolone Acetate – 80 mgBatch No. R05744 / Qty. 160070 Vials imported Batch No. R05897 / Qty. 160000 Vials imported | 2mlVial | 77.41 | 77.73 | 80.83 |
4 | Solo Medrol AOV 40 mg Injection Each Vials contains Methyl Prednisolone Sodium Succinate – 40 mgBatch No. R04764/ Qty. 86898 Vials imported | 1mlVial | 128.86 | 132.76 | 138.07 |
5 | Solu-Medrol AOVEach Vials contains Methyl Prednisolone Sodium Succinate – 125mg Batch No. R05169/ Qty. 73324 Vials | 2mlVial | 246.02 | 252.46 | 262.56 |
6 | Medrol Tablets Each tablet contains Methyl Prednisolone – 4 mgBatch No. H641P / Qty. 20772 Strip importedBatch No. H723A / Qty. 27490 Strip imported | 10×10’s Strip/Blister | 312.39 | 324.14 | 337.11 |
7 | Medrol Tablet Each tablet contains Methyl Prednisolone – 16 mg Batch No. H751A / Qty. 47520 Strip imported Batch No. H751A / Qty. 51718 Strip imported | 14’s Strip/Blister | 137.52 | 142.41 | 148.11 |
*Subject to actual payment of Government levies/taxes, as applicable.
Note :
(a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
(d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
PN/105/2008/F
F. No. 8(14)/2008/D.P./NPPA-Div.-II
(RAJIV WADHAWAN)
Deputy Director
Last Page Updated: 01-06-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)